May 1 2024 |
OSHA’s New Walkaround Rule Potentially Grants Union Representatives Access to Safety Investigations |
Epstein Becker & Green, P.C. |
May 1 2024 |
The Psychology Behind Distracted Driving: Understanding the Urge to Multitask |
Buckfire Law |
Apr 30 2024 |
IRS Notifies Thousands of Taxpayers That They Were Victims of a Data Breach |
Greenberg Traurig, LLP |
Apr 30 2024 |
USPTO Issues Guidance on Use of AI-Based Tools |
Greenberg Traurig, LLP |
Apr 30 2024 |
What the FTC’s Noncompete Ban Means for Healthcare |
Sheppard, Mullin, Richter & Hampton LLP |
Apr 30 2024 |
Lawsuits Filed Challenging the FTC’s Final Rule Banning Non-Competes |
Polsinelli PC |
Apr 30 2024 |
FDA Makes Good on Its Promise to Regulate Laboratory-Developed Tests |
Sheppard, Mullin, Richter & Hampton LLP |
Apr 30 2024 |
United States | USCIS Data Shows Drop in H-1B Registrations This Year |
Berry Appleman & Leiden |
Apr 30 2024 |
NIST Updates AI RMF as Mandated by the White House Executive Order on AI |
Sheppard, Mullin, Richter & Hampton LLP |
Apr 30 2024 |
The Status of Non-Competes in Healthcare: How the FTC Rule and Other Recent Developments Affect Non-Competes for Doctors, Nurses, and Other Healthcare Practitioners |
Squire Patton Boggs (US) LLP |
Apr 30 2024 |
US Producers File Antidumping and Countervailing Duty Petition Against Solar Cells and Panels from Southeast Asia |
Bracewell LLP |
Apr 30 2024 |
Understanding the New FLSA Overtime Rule: What Employers Need to Know |
Strassburger McKenna Gutnick & Gefsky |
Apr 30 2024 |
Supreme Court Declines to Take Up Circuit Split on Whether Courts May Grant Class Certification by Averaging Different Class Member Damages |
Pierce Atwood LLP |
Apr 30 2024 |
FTC Issues Final Rule Banning Non-Competes |
von Briesen & Roper, s.c. |
Apr 30 2024 |
DEA Poised to Reschedule Marijuana |
Bradley Arant Boult Cummings LLP |
Apr 30 2024 |
Carbon Quarterly - Volume 8 |
K&L Gates |
Apr 30 2024 |
This Week in 340B: April 23 – April 29, 2024 |
McDermott Will & Emery |
Apr 30 2024 |
IRS Releases Final Tax Credit Sale Regulations |
Foley & Lardner LLP |
Apr 30 2024 |
New OSHA Walkaround Rule Set for May 31: Union Organizers at Non-Union Sites? |
Barnes & Thornburg LLP |
Apr 30 2024 |
New DOL Exemption Rule Requires Two-Step Salary Increases Under FLSA for Exempt Employees |
Sheppard, Mullin, Richter & Hampton LLP |
Apr 30 2024 |
Mixed Algae Conversion Research Opportunity Will Award up to $18.8 Million to Address R&D Challenges in Converting Algae to Biofuels and Bioproducts |
Bergeson & Campbell, P.C. |
Apr 30 2024 |
EEOC Publishes Long-Awaited Final Guidance on Workplace Harassment |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Apr 30 2024 |
It’s Been a Long Time Coming – FDA’s Final Rule on Regulation of Laboratory Developed Tests (LDTs) as Medical Devices Has Arrived |
Epstein Becker & Green, P.C. |
Apr 30 2024 |
Senate Subcommittee Will Hold Hearing on May 1 on EPA’s FY 2025 Budget |
Bergeson & Campbell, P.C. |
Apr 30 2024 |
EEOC Updates Workplace Harassment Guidelines Reinforcing Protections for LGBTQ+ Employees (US) |
Squire Patton Boggs (US) LLP |
Apr 30 2024 |
Trade Secret Law Evolution Podcast, Episode 64: The FTC’s Non-Compete Decree [Podcast] |
Greenberg Traurig, LLP |
Apr 30 2024 |
The Macro-Economic Environment: What It Means for VC Firms |
Proskauer Rose LLP |
Apr 30 2024 |
Federal Cyber Enforcement Hits Crypto Hard, But Crypto is Hitting Back |
Katz Banks Kumin LLP |
Apr 30 2024 |
BIS Authorizes Medical Device Exports to Russia, Belarus, and Occupied Ukraine (With Strings Attached) |
ArentFox Schiff LLP |
Apr 30 2024 |
The 10 Trends and Legal Challenges We Are Tracking Throughout 2024 |
ArentFox Schiff LLP |
Apr 30 2024 |
“Dollars and Sense” – Understanding the DOL’s New Salary Requirements for FLSA-Exempt Employees |
Hunton Andrews Kurth |
Apr 30 2024 |
FSIS Declares Salmonella an Adulterant in Chicken Products |
Keller and Heckman LLP |
Apr 30 2024 |
CMS Releases Final Rule: Medicaid Program; Ensuring Access to Medicaid Services |
McDermott Will & Emery |
Apr 29 2024 |
EPA Issues Asbestos Part 2 Draft Risk Evaluation, Preliminarily Determines That Asbestos Poses Unreasonable Risk to Human Health |
Bergeson & Campbell, P.C. |
Apr 29 2024 |
Supreme Court Holds that Pure Omissions are not Actionable Under Rule 10b-5(b) in MACQUARIE INFRASTRUCTURE CORP. v. MOAB PARTNERS, L. P. |
Stubbs Alderton & Markiles, LLP |